Alexander M.M. Eggermont
Beth Israel Deaconess Medical Center
2 papers in the Anchorcite directory, published between 2009 and 2017, cited 10,470 times in total.
ORCID profileResearch topics
- T-cell and B-cell Immunology · 1 paper
- Cancer Immunotherapy and Biomarkers · 1 paper
- Gut microbiota and health · 1 paper
- Breast Cancer Treatment Studies · 1 paper
- Cutaneous Melanoma Detection and Management · 1 paper
- Melanoma and MAPK Pathways · 1 paper
Frequent co-authors
- Bertrand Routy · 1 paper
- Emmanuelle Le Chatelier · 1 paper
- Lisa Derosa · 1 paper
- Connie P.M. Duong · 1 paper
- Maryam Tidjani Alou · 1 paper
- Romain Daillère · 1 paper
- Aurélie Fluckiger · 1 paper
- Meriem Messaoudene · 1 paper
Papers
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsScience · 2017 · 5,814 citations
Good bacteria help fight cancer Resident gut bacteria can affect patient responses to cancer immunotherapy (see the Perspective by Jobin). Routy et al. show that antibiotic consumption is associated with poor response to immunotherapeutic PD-1 blockade. They profiled samples from…
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology · 2009 · 4,656 citations
PURPOSE: To revise the staging system for cutaneous melanoma on the basis of data from an expanded American Joint Committee on Cancer (AJCC) Melanoma Staging Database. METHODS: The melanoma staging recommendations were made on the basis of a multivariate analysis…
Metadata from OpenAlex (CC0).